group 11-15

Question 1

what is immunogen

Answer 1

clinical stage company acquired by abbvie

Question 2

what is the platform of immunogen

Answer 2

antibody drug conjugates used in cancer treatment

Question 3

technology and ip of immunogen

Answer 3

targets cancer cells and cancer cells only via the use of cancer-killing toxins conjugated
to cancer cell antibodies

Question 4

what is fusion pharmaceutical

Answer 4

clinical stage oncology company focused on developing next gen radiopharmaceuticals as precision medecine

Question 5

what is the platform of fusion pharmaceutical

Answer 5

Targeted Alpha Therapies with Fast-ClearTM Linker technology to connect alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumours

Question 6

what is macrogenetics

Answer 6

clinical stage biopharmaceutical company

Question 7

platform of macrogenerics

Answer 7

latform includes multiple antibody technologies – primarily for the treatment of cancer.
o mAbs, ADCs, multi-specific Abs (DART® and TRIDENT®) which includes Next-Gen T-Cell engagers

Question 8

what is avidity bioscience

Answer 8

clinical stage biopharmaceutical company focused on utilizing their tech to develop rna therapeutics

Question 9

what is the platform of avidity bioscience

Answer 9

Proprietary Antibody Oligonucleotide Conjugates (AOC ), which combines the specificity of monoclonal
antibodies and the precision of oligonucleotides, to unlock the treatment for rare muscle diseases and for other rare
and common diseases.

Question 10

what is ascendis pharma

Answer 10

clinical stage biopharmaceutical company that combines technological and therapeutics based approach

Question 11

what is the platform of ascendis pharma

Answer 11

transcon (transient conjugation) technology

Question 12

what is the platform of lyell immunopharma

Answer 12

-advanced cellular engineering with proprietary genetic and epigenetic reprogramming technologies
-targeting solid tumors with innovative therapies like lyl979

Question 13

what is lyell immunopharma

Answer 13

pioneers in t cell programming for the treatment of solid tumors

Question 13

what is biomarin pharmaceutical

Answer 13

glonal biotech company focused on using genetics and molecular biology to develop for rare disease

Question 13

what is the tech platform for biomarin pharmaceuticals

Answer 13

-enzyme replacement therapy: providing synthetic copies of missing proteins to people with genetic conditions
-using adeno associated virus gene therapy for dna to cells

Question 14

what is legend biotech

Answer 14

pioneed and leader in cell therapy
-has global collaboration in china, us, japan and europe

Question 15

what is the platform for legend biotech

Answer 15

car-t cell therapies to improve cancers such as multiple myeloma

Question 16

what is precigen inc

Answer 16

discovery and clinical stage biopharmaceutical company

Question 17

what is the platform for precigen inc

Answer 17

-ultracar-t cells
-focused on the development of gene and cell therapies for immuno-oncology, autoimmune and infectious diseases
-done through precision immunology with a framework of multifunctional therapies designed to work in combination

Question 18

what is prothena

Answer 18

late stage clinical biotech

Question 19

what is the platform for prothena

Answer 19

antibodies that target misfolded proteins, small molecules and vaccines

Question 20

what is alector

Answer 20

clinical stage biopharmaceutical, pioneering immuno-neurology, using insights into human genetics, immunology and neuroscience

Question 21

what is the platform of alector

Answer 21

monoclonal antibodies

Question 22

what is intellia

Answer 22

clinical stage biopharmaceutical company

Question 23

what is the platform for intella

Answer 23

crispr based genome editing technologies for human therapeutic use

Question 24

what is anavex

Answer 24

clinical stage biopharmaceutical company

Question 25

what is the platform of anavex

Answer 25

small molecule therapeutics that modulate sigma receptor 1 (sigmar1)

Question 26

whay is alnylam

Answer 26

biopharmaceutical company

Question 27

what is the platform of alnylam

Answer 27

Focused on discovering, developing, and commercializing RNAi therapeutics in genetic medicines, cardio-metabolic diseases, infectious diseases, central nervous system, and ocular diseases.

Question 28

what is ionis

Answer 28

Clinical stage pharmaceutical company specializing in discovery and development of RNA targeted medicines and gene editing to treat neurological and cardiometabolic diseases

Question 29

what is platform of ionis

Answer 29

Antisense therapies to target specific mRNAs for degradation to decrease levels of disease-causing protein. In some cases, antisense therapies may also be used to increase production of deficient mRNAs.

Question 30

what is arrowhead pharmaceuticals

Answer 30

clinical stahe biopharma company focusing on rnai tech

Question 31

what is the plastform of arrowhead pharma

Answer 31

rnai molecule trim platform leberages the body's natural pathway to silence disease causing genes by triggering risc

Question 32

what is arbutus biopharma

Answer 32

clinical stage biopharmaceutical focused on chronic hep B treatment

Question 33

what is the platform of arbutus biopharma

Answer 33

combination therapy with rna interference (rnai) therapeutic and oral pd-L1 inhibitor to suppress HBV dna, reduce viral antigens and bost host immune response

Question 34

what is janux therapeutics

Answer 34

clinical stage biotech focused on the development of improved T cell engagers for the treatment of solid tumor cancers

Question 35

what is the platform of janux therapeutics

Answer 35

Tumor-Activated T Cell Engager (TRACTr) and Immunomodulator (TRACIr) platforms * Enhanced specificity, stability, and sensitivity promises reduced limitations of canonical TCEs: CRS, off-target toxicities, poor PK

Question 36

what is xencor

Answer 36

clinical stage biopharmaceutical company focused on engineering antibodies and citokines for the treatment of patients with cancer and autoimmune diseases

Question 37

what is the platform of xencor

Answer 37

-XmAb protein engineering platform * XmAb Fc Domains augment native immune functions and/or control structure to preserve halflife, stability, and production of antibody treatments

Question 38

what is merus NV

Answer 38

clinical stage pharmaceutical company

Question 39

what is the platform of merus NV

Answer 39

-Multiclonics® Technology o Technology: Developed novel, full length human IgG antibodies capable of binding multiple targets while maintaining the long half-life and low immunogenicity of conventional monoclonal antibodies o Created Biclonics® and Triclonics® technologies, through which these antibodies bind 2 or 3 targets, respectively

Question 40

what is immunocore

Answer 40

leading biotech company focused on T cell receptor tech to develop therapies for cancer, infectuous diseases and autoimmune disorders

Question 41

what is the platform of immunocore

Answer 41

-Their novel ImmTAX molecules enhance immune recognition to eliminate infected or cancerous cells. *KIMMTRAK, the first approved TCR therapy for metastatic uveal melanoma, targets the gp100 antigen.